Clinical trial

Study of the Combination of Tivantinib Plus Pemetrexed and Carboplatin

NCT02049060

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Tivantinib Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study of the Combination of Tivantinib Plus Pemetrexed and Carboplatin

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1, PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-01-01

PhasePHASE1 / PHASE2

Conditions

Malignant Pleural Mesotheliomaverified · MONDO: malignant pleural mesothelioma

Nonsquamous Nonsmall Cell Neoplasm of Lungunresolved

Interventions

TivantinibDRUG

Sponsors & collaborators

Armando Santoro, MDlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02049060 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.